Product Wiki · Recalls · Canadian Food Inspection Agency

Undeclared milk in Primo brand Hearty Chicken Soup — recall 48908

Canadian Food Inspection Agency · Canada · 2011-10-07 · Class 1

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Canadian Food Inspection Agency
Recall identifier
48908
Date of alert
2011-10-07
Country / jurisdiction
Canada
Risk level
Class 1
Risk type
recall
Product category
Food
Product type
CFIA
Notice status
Archived by the issuing authority — kept for reference
Reported risk: Ottawa, October 7, 2011 - The Canadian Food Inspection Agency (CFIA) and Baxters Canada Inc. are warning people with allergies to milk not to consume the Primo brand Hearty Chicken Soup described below. The affected product contains milk which is not declared on the label. The affected product, Primo brand Hearty Chicken Soup, is sold in 525 ml cans bearing UPC 0 55900 00554 9 and lot code EST 142 2356 9 230. The affected cans contain Minestrone soup, which has milk ingredients. This product has been distributed nationally. There have been no reported illnesses associated with the consumption of this product. Consumption of this product may cause a serious or life-threatening reaction in persons with allergies to milk. The manufacturer, Baxters Canada Inc. , St -Hyacinthe, QC , is voluntarily recalling the affected product from the marketplace. The CFIA is monitoring the effectiveness of the recall.
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/undeclared-milk-primo-brand-he

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.